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ABSTRACT
The aim of this study was to find out how Slo-
venian family physicians (FPs) would manage a hy-
pothetical clinical case, to explore their views about 
possible ethical dilemmas associated with this clini-
cal case and to determine possible associations with 
demographic and other characteristics of FPs. This 
was an observational cross-sectional postal study in 
the Slovenian FPs’ surgeries. The study population 
consisted of the whole population of Slovenian FPs 
(n = 950). The main outcome measures were the per-
centages of the answers of FPs on different questions 
about the clinical case on the management of patient 
and his relative with hereditary cardiomyopathy.
There were 271 FPs who answered the question-
naire (response rate was 27.1%). A sample included 
66 (24.4%) men and the mean age of all respondents 
was 45.5 ± 10.6 years. When dealing with the clini-
cal case, most FPs expressed willingness to take the 
patient’s family history. Only 34.2% FPs did not be-
lieve that ordering genetic tests was part of their job. 
Additionally, only 50.0% of them felt competent to 
interpret the genetic risk, 25.0% of them would give 
information about genetic testing and only 6.0% 
would interpret the results of the genetic testing.
Family physicians in Slovenia were willing to 
include genetic tasks into routine management of 
their patients, but they do not feel competent enough 
to interpret the genetic risks and the results of genet-
ic testing. However, an important part of FPs would 
not refer patients at risk to genetic counseling. The 
inclusion of genetic topics to family medicine spe-
cialization curriculum is needed.
Keywords: Case management; Family medi-
cine; Genetics.
INTRODUCTION
Preventive activities are an important part of 
patient management at primary health level. Taking 
into account the effect of family and society when 
dealing with individual patients is also one of the 
core competencies of family medicine [1]. In the 
era of rapid evolvement of genetic medicine, fam-
ily physicians (FPs) increasingly face the activities 
and dilemmas associated with the management of 
genetic aspects of disease and prevention [2].
Genetics is rarely taught at the undergraduate 
and postgraduate level of medical education of non 
genetic specialities [3]. It has already been shown 
that FPs had low confidence in their ability to carry 
out basic medical genetic tasks [4] but were aware 
of their need for additional education and even ex-
pressed their educational needs [5].
Even though family history is a crucial part of pa-
tient management in family medicine, its association 
with possible genetic background of disease develop-
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ment and higher disease risk is not yet fully used in 
practice [6,7]. Traditionally, family history taking is 
focused on the patients with symptoms or problems, 
which might imply that the patient is having a higher 
risk for the development of some chronic diseases, such 
as diabetes, coronary disease or asthma [8]. Healthy 
patients or patients’ relatives are rarely being asked 
about their family history [9] Also, FPs very rarely de-
cide to refer patients at risk to clinical genetics [10].
Family physicians regularly face ethical di-
lemmas in their everyday practice [11] and find the 
management of some of them quite difficult [12]. 
Genetic medicine is undoubtedly associated with 
many ethical dilemmas [13]. Similarly, many di-
lemmas can also be encountered when performing 
preventive activities such as screening for some dis-
eases [14]. Therefore, the field of genetics in pre-
ventive activities performed in patients and their 
healthy relatives is a very sensitive area. Combined 
with the lack of knowledge of genetics [15], the FPs 
may face serious difficulties and doubts, and may 
feel reluctant to perform such activities even though 
genetic concepts are clearly part of current FPs 
practice in form of clinical decision making based 
on family history [16,17]. This was also shown in 
a clinical case scenario-based study with more than 
60.0% of FPs who were willing to take family his-
tory but only 16.0% willing to order a genetic test 
[18]. Similarly, primary care providers seem to as-
sess breast cancer risk mainly by family history but 
rarely discuss genetic testing with the patients [10].
In Slovenia, as in many other European coun-
tries [3], genetic medicine is taught at the under-
graduate level. However, it is not taught as a part 
of family medicine specialization curriculum [19]. 
The aim of this study was to find out how Slovenian 
FPs would manage a hypothetical clinical case and 
to explore their views about possible ethical dilem-
mas associated with this clinical case.
MATERIALS AND METHODS
Study Design. This observational cross-sec-
tional postal study was conducted in Slovenia. It 
was approved by the Slovenian Ethics Committee 
(No. 40/09/12).
Participants. All Slovenian FPs were invited 
to participate in the study. According to the inter-
nal data of the Slovenian Medical Chamber (mem-
bership is obligatory for all Slovenian physicians), 
there were 950 working FPs in Slovenia at the time 
of the study.
Data Collection. We collected data by a postal 
survey sent in March 2013. The mail consisted of 
the questionnaire (described below), the invitation 
letter, and a pre stamped return envelope.
Table 1. Demographic and professional characteristics of family physicians in a sample. 
Characteristic Number ofFamily Physicians
Percentage of
Family Physicians
Males
Females
 66
205
24.4
75.6
Education:
∙ family medicine specialist
∙ family medicine resident
∙ specialist in other fields
∙ without any specialization
216
 50
 4
 1
79.7
18.5
 1.5
 0.4
Involved in education of students and/or residents 112 41.8
Education in genetics:
∙ none
∙ genetic content during undergraduate studies
∙ genetic content in specialist training
∙ genetic content in courses
∙ genetic content in postgraduate studies
 39
220
 6
 1
 4
14.4
81.5
 2.2
 0.4
 1.5
Number of inhabitants living in practice catchment area:
∙ less than 5000
∙ 5000-20,000
∙ 20,000-100,000
∙ more than 100,000
49
88
63
70
18.1
32.5
23.2
25.8
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We used the internationally validated [4,5,18,20] 
questionnaire that was developed as a part of the 
European Union (EU) project “Genetic Education, 
Improving Non-Health Professionals Understand-
ing of Genetic Testing (EU 5th framework research 
– GenED).” First, the questionnaire was translated 
into the Slovenian language by two independent 
experts who agreed on its Slovenian version. Two 
independent experts then translated it back into the 
English language. Finally, both experts agreed on 
the final version of the Slovenian questionnaire.
The questionnaire consisted of the demograph-
ic questions (see Table 1) and questions about pre-
vious attendance to genetic education (see Table 1), 
of the scenario of clinical case and the questions on 
how to manage it, of the questions about the use 
of genetic knowledge in everyday management of 
patients, of the questions on the educational needs 
of FPs and of the questions on the self-perceived 
importance of providing genetic tests’ information 
(see Tables 2 and 3). In Table 2, items 1-9 could be 
answered with the following options: family physi-
cian, cardiologists, genetic specialist. We dichoto-
mized the answers into two categories: family phy-
sician/other for the purpose of statistical analysis. In 
Table 3, items 10-18 could be answered with most 
likely, likely, unlikely and no. Again, we dichoto-
mized the answers into two categories: yes/no, in-
cluding most likely and likely to “yes” and unlikely 
and no to “no”. Only the data on the management 
of patients described in the scenario and its associa-
tions with demographic and other characteristics of 
FPs are reported in this article.
The Scenario of a Clinical Case. Mr. Smith 
(aged 35) came to your surgery because his 27-year-
old brother, a competitive swimmer, has just died 
suddenly. He collapsed in the pool and despite de-
fibrillation was found to be dead. Although sudden 
death might not immediately suggest a genetic con-
dition, Mr Smith is worried because his mother’s 
sister died suddenly aged 30 and he asks whether 
the same may happen to him, his children Melanie 
(12 years), and Tom (6 months) or his brother (32 
years). He has been told that his brother’s postmor-
tem demonstrated hypertrophic obstructive cardio-
myopathy, which can be inherited as an autosomal 
dominant condition. Eighty percent of non trau-
matic sudden deaths in young athletes are due to in-
Table 2. Willingness of family physicians to carry out tasks related to the management of genetic patients in family medicine.
n Task Number (%) of Family PhysiciansWilling to Perform the Task
 1 Taking a family history 200 (73.8)
 2 Explaining the inheritance pattern 136 (50.2)
 3 Explaining the genetic risk to Mr. Smith’s children  73 (50.2)
 4 Giving information about available genetic tests  69 (25.6)
 5 Informing Mr. Smith of the implication of no mutation being found  50 (18.5)
 6 Informing Mr. Smith of the implications of a mutation being found  41 (15.2)
 7 Ordering the genetic test  92 (34.2)
 8 Explaining the test results  17 (6.3)
 9 Explaining the implications of the test results for Mr. Smith’s children  14 (5.2)
10 Tell Mr. Smith it is his responsibility to inform his brother 193 (76.0)
11 Ask Mr. Smith to convince his brother that he should be tested 130 (51.0)
12 Let Mr. Smith decide whether or not he wants to inform his brother  83 (34.0)
13 Ask Mr. Smith to advise his brother to see you or another family physician for counseling  about his genetic risk 232 (89.2)
14 Refer Mr. Smith to a genetic specialist for advice on how to handle the situation 193 (74.2)
15 Refer Mr. Smith to a cardiologist for advice on how to handle the situation 179 (71.6)
16 Respect Mr. Smith’s wish not to inform his bother  85 (34.1)
17 Offer to contact Mr. Smith’s brother to inform him 238 (91.2)
18 On his next visit inform the brother who is a patient and attends your practice 190 (73.9)
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herited or congenital cardiovascular abnor-malities 
and hypertrophic cardiomyopathy (HCM) accounts 
for 40.0-50.0% of these. Genetic testing may lead 
to identification of patients at high risk for sudden 
death as early as 10 years of age. Treatment can be 
considered with implantable defibrillators or medi-
cation. Mr Smith has agreed to be tested and the 
inherited mutation has been found but he does not 
want to inform his brother.
Data Analysis. We analyzed the data by the 
Statistical Package for the Social Sciences (SPSS) 
version 13.0 (SPSS for Windows; SPSS Inc., Chi-
cago, IL, USA). We performed the descriptive anal-
ysis. In the bivariate analysis, we used the indepen-
dent t-test and c2 test. We set the limit for statistical 
significance at a p value of <0.05.
RESULTS
There were 271 (27.1%) FPs who completed the 
questionnaire, out of which 66 (24.4%) were men and 
205 (75.6%) were women (Table 1). Mean age of the 
sample was 45.5 ± 10.6 years. Mean age of the men 
was 50.1 ± 11.8 and mean age of the women was 43.9 
± 9.7 (p <0.001). Mean working period of the sample 
was 17.3 ± 11.6 years and mean time from graduation 
19.6 ± 10.9 years. Mean number of patient seen by 
the FP in the previous week was 213.7 ± 77.7.
When dealing with the clinical case, most FPs 
expressed willingness to take Mr. Smith’s family 
history. More than 70.0% of FPs would tell Mr. 
Smith that it was his responsibility to tell his brother 
about the genetic risk and almost 90.0% would tell 
Mr. Smith to tell his brother to come to see them. In 
the last case, more than 90.0% of FPs would inform 
Mr. Smith’s brother about the risk by themselves 
(Table 2).
Younger FPs were more inclined to give the 
information to Mr. Smith (t = –2.040, p = 0.042). 
Similar associations were found regarding years 
from graduation (t = –2.054, p = 0.041). Younger 
FPs (and those with less working years) would also 
more likely respect the wish of Mr. Smith not to in-
form his brother about the mutation (t = –2.112, p = 
0.036; t = –2.065, p = 0.040; respectively). On the 
other hand, older FPs, FPs with more working years 
and with more time since graduation would inform 
Mr. Smith’s brother on his next visit to the practice 
(t = 3.112, p = 0.002; t = 2.823, p = 0.005; t = 2.925, 
p = 0.004). Similar findings were detected also in 
terms of association of age/years from graduation/
working experiences and respecting or disrespect-
ing the patient’s wish regarding his brother and re-
ferrals to clinical specialists (Table 3).
DISCUSSION
More than 70.0% of Slovenian FPs believe that 
taking family history is a part of their everyday job. 
On the other hand, up to 70.0% of them do not be-
Table 3. Association between willingness of family physicians to carry out tasks related to the management of genetic patients in 
family medicine and some demographic and professional family physicians’ characteristics. 
Task 
(see
Table 2)
Gender Age (years) Genetic Education Specialist ofFamily Medicine
Years from
Graduation
Working 
Experience (years)
M vs. F
(%) p Value t Value p Value
Yes vs. No
(%) p Value
Yes vs. No
(%) p Value t Value p Value t Value p Value
 4 24.2 vs. 26.0 0.872 –2.040  0.042 27.4 vs. 25.6 1.000 24.1 vs. 31.5 0.296 –2.054  0.041  0.001  1.000
 5 21.2 vs. 17.6 0.585 –2.112  0.036 18.7 vs. 17.9 1.000 18.1 vs. 20.0 0.846 –2.065  0.040 –1.645  0.101
11 59.7 vs. 48.2 0.144  3.112  0.002 49.8 vs. 60.0 0.280 52.7 vs. 44.2 0.282  2.823  0.005  2.925  0.004
12 37.9 vs. 32.8 0.526 –3.077  0.002 33.8 vs. 33.3 1.000 32.1 vs. 41.2 0.247 –3.098  0.002 –2.943  0.004
14 90.6 vs. 88.8 0.818 –2.139  0.033 76.9 vs. 57.9 0.017 72.3 vs. 81.5 0.221 –2.154  0.032 –2.486  0.014
15 81.0 vs. 72.1 0.187 –1.602  0.110 74.1 vs. 59.5 0.077 68.2 vs. 84.6 0.024 –1.399  0.163 –1.850  0.066
16 25.8 vs. 36.9 0.124 –3.634 <0.001 33.0 vs. 41.7 0.344 31.5 vs. 44.9 0.093 –3.584 <0.001 –3.562 <0.001
17 92.1 vs. 90.9 1.000  1.320  0.188 92.9 vs. 80.6 0.025 91.3 vs. 90.6 0.791  1.111  0.268  1.532  0.127
18 86.2 vs. 69.8 0.009  4.626 <0.001 74.5 vs. 69.4 0.542 76.3 vs. 64.0 0.105  4.568 <0.001  4.453 <0.001
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lieve that ordering and discussing genetic tests or 
their implications is part of their job. Additionally, 
only 50.0% of them feel competent to interpret the 
genetic risk, 25.0% of them would give information 
about genetic testing and only 6.0% would interpret 
the results of the genetic testing.
This is the first study on FPs’ attitudes to ge-
netic management of patients in Slovenia and also 
in the southeastern part of Europe. A study using 
the same questionnaire and also the same clinical 
case scenario was conducted in France, Germany, 
The Netherlands, Sweden and the UK, and showed 
that 61.0% of FPs would take a family history but 
only 38.0% would explain an inheritance pattern 
and 16.0% would order a genetic test [18]. In our 
study, the percentages of FPs taking a family his-
tory are higher than in the previously mentioned 
European studies. Also, Slovenian FPs seem to be 
more willing to engage in other genetic activities 
(i.e., explaining the inheritance pattern, ordering a 
genetic test) than their colleagues from some Euro-
pean countries, even though the percentage of them 
willing to do so is still low. A similar study on the 
FPs’ views on their role in cancer genetic services 
showed that 60.0% of them would take a detailed 
family history from the patient, almost 80.0% would 
decide which patients should be referred to genet-
ics clinic and a quarter of them would counsel the 
patient on cancer risk [21]. It seems that FPs were 
willing to engage in genetic activities but clearly 
distinguish between the routine use and function of 
family history in clinical decision making and con-
trasting conceptualizations of genetics and genetic 
conditions as shown by Mathers et al. [16]. Fam-
ily physicians seem to be willing to embrace genet-
ics as a part of their work from the aspect of core 
competencies of family medicine (comprehensive 
approach) and not from an isolated clinical genet-
ics view. Nevertheless, they expressed a very strong 
opinion about family history taking as their task and 
we have to take into account that family history is a 
basic genetic tool [22,23].
Each time a genetic test is undertaken by physi-
cians or by patients themselves, its results will inev-
itably affect not only the life of the patients but also 
of their relatives. Confidentiality is one of the basic 
principles that have to be followed by any physician 
[24]. However, in some cases (i.e., a duty to warn 
relatives about risk of some infectious diseases or 
to warn public about an imminent harm) physi-
cians are legally allowed to breach confidentiality. 
As far as the notification of family members of the 
identification of a genetic mutation by physicians is 
concerned, no clear answer yet exists [25]. It is an 
example of a conflict between the physician’s ethi-
cal obligations to respect the privacy of genetic in-
formation and the potential liabilities resulting from 
the physician’s failure to notify at risk relatives 
[26]. According to our study, FPs believe that it is 
the patients’ responsibility to notify their relatives 
at risk and they would even encourage patients to 
do so. A majority of them would even offer to help 
them to inform their relatives. Similarly, UK physi-
cians considered informing family members about 
genetic risk as a family responsibility [27]. Over 
two-thirds of medical geneticists in a the USA study 
[28], believed they should bear the responsibility of 
warning their patients’ relatives when found to be at 
risk for genetic disease. However, only one quarter 
of those who faced the dilemma of a patient refus-
ing to notify their at risk relatives seriously consid-
ered disclosure to those at risk relatives without the 
patient’s consent [28]. In our study, almost 70.0% 
of FPs would not respect the patients’ wishes not 
to inform their relatives and would inform them by 
themselves when first seeing them in the practice. 
Clearly, FPs are not clear about the correct proce-
dure of informing relatives about genetic risk but 
according to other studies, this is a wider problem 
which has not yet been solved [29].
The results of our study highlighted some dif-
ferences regarding demographic and professional 
characteristics. The most obvious one was age. It 
seems that younger FPs were more willing to in-
clude genetic tasks into their everyday practice. 
Also, they appeared to be more sensitive to ethical 
issues. A study based on the same clinical case [18] 
showed some differences regarding gender: male 
FPs seemed to be more willing to perform genetic 
tests. In our study, male FPs were only found to be 
more inclined to inform Mr. Smith’s brother about 
the genetic risk. Taking into account that similar 
associations as with age were found also regard-
ing working years and years since graduation, the 
differences might be the consequence of the previ-
ous finding that the younger generation was more 
confident in their abilities about genetic tasks and 
have more genetic knowledge [4,15]. The older 
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generation, on the other hand, usually did not want 
to change their steady management of patients. 
We also observed differences regarding education 
as the physicians with more genetic education and 
those with the family medicine specialization would 
be more willing to refer patients to genetic and/or 
cardiovascular assessment.
Greater sensibility of younger and more edu-
cated FPs could be the consequence of a new pro-
gram of family medicine specialization, which also 
introduced ethical topics to the curriculum [19]. 
This was also shown by previous studies in Slove-
nia [12,30]. These findings indicate the need for the 
introduction of genetic topics to family medicine 
specialization curriculum.
This study was performed in a representative 
sample of Slovenian FPs and its findings can there-
fore be generalized to the whole population of FPs 
in Slovenia. The strength of this study is also the use 
of a previously validated questionnaire which gives 
us confidence in the reliability of data. This was a 
cross-sectional study so it is not possible to detect 
any causal relationship between variables. The re-
sponse rate in this study was expected, as a 20.0% 
response rate is usual for postal surveys [12,31]. 
Nevertheless, it can be a source of selection bias. 
Also, the use of a theoretical clinical case represents 
simulated environment, thus in reality, physicians 
might have decided differently.
CONCLUSIONS
Family physicians in Slovenia seem to be will-
ing to include genetic tasks into routine manage-
ment of their patients but they do not feel competent 
enough to interpret the genetic risks and the results 
of genetic testing. However, a great percentage of 
FPs would not refer patients at risk to genetic coun-
seling. Family physicians are aware of their duty of 
providing information in order to prevent harm but a 
great many of them would choose not to respect their 
patients’ wishes regarding confidentiality issues.
Family physicians are in need of additional in-
formation on their role in genetic management of 
patients and clear guidelines on ethical issues. Fur-
ther studies should be directed to the assessment of 
genetic knowledge in FPs, on the assessment of in-
practice management of their patients in terms of 
genetic medicine and on deeper exploration of FPs’ 
attitudes towards ethical issues associated with ge-
netic medicine.
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